N1-((S)-2-((S)-3-hydroxypyrrolidin-1-yl)-1-phenylethyl)-N1-methyl-N3-(pyridin-3-yl)malonamide

ID: ALA425836

PubChem CID: 11440457

Max Phase: Preclinical

Molecular Formula: C21H26N4O3

Molecular Weight: 382.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(C(=O)CC(=O)Nc1cccnc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1

Standard InChI:  InChI=1S/C21H26N4O3/c1-24(21(28)12-20(27)23-17-8-5-10-22-13-17)19(16-6-3-2-4-7-16)15-25-11-9-18(26)14-25/h2-8,10,13,18-19,26H,9,11-12,14-15H2,1H3,(H,23,27)/t18-,19+/m0/s1

Standard InChI Key:  QRMWODNOOLVFGC-RBUKOAKNSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  1  0  0  0  0  0999 V2000
    0.5944  -22.3458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5932  -23.1732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3081  -23.5860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0245  -23.1727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0216  -22.3422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3063  -21.9330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3079  -24.4110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5933  -24.8234    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5931  -25.6484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1211  -24.4107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0222  -24.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7368  -24.4114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4864  -24.7467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0386  -24.1337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6262  -23.4191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8192  -23.5905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8590  -24.2201    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1209  -23.5857    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8357  -24.8230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5500  -24.4103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5498  -23.5853    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2646  -24.8227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9790  -24.4100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9800  -23.5856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6935  -23.1730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4090  -23.5853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4066  -24.4146    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6925  -24.8235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  3  1  0
  3  4  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
  7  8  1  0
 14 17  1  6
 10 18  2  0
  8  9  1  0
 10 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 20 21  2  0
  2  3  1  0
 20 22  1  0
  7 11  1  1
 22 23  1  0
  5  6  2  0
 23 24  2  0
 11 12  1  0
 24 25  1  0
 12 13  1  0
 25 26  2  0
  6  1  1  0
 26 27  1  0
  1  2  2  0
 27 28  2  0
 28 23  1  0
M  END

Associated Targets(Human)

OPRK1 Tclin Opioid receptors; mu & kappa (822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Opioid receptors; delta & kappa (935 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 382.46Molecular Weight (Monoisotopic): 382.2005AlogP: 1.68#Rotatable Bonds: 7
Polar Surface Area: 85.77Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.12CX Basic pKa: 8.23CX LogP: 0.59CX LogD: -0.30
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -1.19

References

1. Chu GH, Gu M, Cassel JA, Belanger S, Graczyk TM, DeHaven RN, Conway-James N, Koblish M, Little PJ, DeHaven-Hudkins DL, Dolle RE..  (2007)  Novel malonamide derivatives as potent kappa opioid receptor agonists.,  17  (7): [PMID:17307360] [10.1016/j.bmcl.2007.01.053]

Source